Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6535824> ?p ?o }
Showing triples 1 to 21 of
21
with 100 triples per page.
- Q6535824 subject Q8728165.
- Q6535824 subject Q8808791.
- Q6535824 abstract "Levormeloxifene is an experimental selective estrogen receptor modulator that was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss. The development was stopped because of a high incidence of gynaecologic adverse events during clinical trials. It is the enantiomer of ormeloxifene.".
- Q6535824 iupacName "1-(2-{4-[(3R,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenoxy}ethyl)pyrrolidine".
- Q6535824 thumbnail Levormeloxifene.svg?width=300.
- Q6535824 wikiPageWikiLink Q1931705.
- Q6535824 wikiPageWikiLink Q30612.
- Q6535824 wikiPageWikiLink Q494483.
- Q6535824 wikiPageWikiLink Q7103387.
- Q6535824 wikiPageWikiLink Q8728165.
- Q6535824 wikiPageWikiLink Q8808791.
- Q6535824 wikiPageWikiLink Q903917.
- Q6535824 iupacname "1".
- Q6535824 type ChemicalCompound.
- Q6535824 type ChemicalSubstance.
- Q6535824 type ChemicalObject.
- Q6535824 type Thing.
- Q6535824 type Q11173.
- Q6535824 comment "Levormeloxifene is an experimental selective estrogen receptor modulator that was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss. The development was stopped because of a high incidence of gynaecologic adverse events during clinical trials. It is the enantiomer of ormeloxifene.".
- Q6535824 label "Levormeloxifene".
- Q6535824 depiction Levormeloxifene.svg.